Axel Bolte, Director at PTC THERAPEUTICS, INC. (PTCT), bought 20,000 shares at $15.00 ($300K) on 2013-06-25, disclosed to the SEC on 2013-06-27.
Open-market purchase of $300k PTCT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| OPHT | BUY | 2016-06-07 | $199K | — | Filing → |
| OPHT | BUY | 2015-04-01 | $24K | — | Filing → |
| OPHT | BUY | 2013-10-07 | $44K | — | Filing → |